28 May, 2025Enthera Pharmaceuticals Announces Publication in the Journal of Clinical Investigation Supporting the Clinical Development of Ebrasodebart
27 May, 2025GlycoEra AG raises $130 million to advance novel pipeline of extracellular protein degraders for the treatment of autoimmune diseases
18 March, 2025Forth Tx launches with backing from Sofinnova Partners to revolutionize fibrosis treatments
18 March, 2025BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies